156 related articles for article (PubMed ID: 38831709)
1. A systematic review of case-control studies of cytokines in blister fluid and skin tissue of patients with Stevens Johnson syndrome and toxic epidermal necrolysis.
Stewart TJ; Farrell J; Frew JW
Australas J Dermatol; 2024 Jun; ():. PubMed ID: 38831709
[TBL] [Abstract][Full Text] [Related]
2. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
4. The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Sadek M; Iqbal O; Siddiqui F; Till S; Mazariegos M; Campbell E; Mudaliar K; Speiser J; Bontekoe E; Kouta A; Farooqui A; Daravath B; Qneibi D; Sadek R; Hoppensteadt D; Fareed J; Bouchard C
Clin Appl Thromb Hemost; 2021; 27():1076029620950831. PubMed ID: 33560872
[TBL] [Abstract][Full Text] [Related]
5. Variable levels of apoptotic signal-associated cytokines in the disease course of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Yang Y; Li F; Du J; Shen Y; Lin J; Zhu X; Luo X; Liang J; Xu J
Australas J Dermatol; 2017 Aug; 58(3):e61-e67. PubMed ID: 27040133
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine.
Chen CB; Wang CW; Chung WH
Methods Mol Biol; 2022; 2486():37-54. PubMed ID: 35437717
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hasegawa A; Abe R
F1000Res; 2020; 9():. PubMed ID: 32595945
[TBL] [Abstract][Full Text] [Related]
8. Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Carr DF; Wang CW; Bellón T; Ressel L; Nwikue G; Shrivastava V; Bergfeld W; Jorgensen AL; Chung WH; Pirmohamed M
Br J Dermatol; 2019 Jul; 181(1):166-174. PubMed ID: 30613954
[TBL] [Abstract][Full Text] [Related]
9. TNF-α induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis.
Nwikue G; Olsson-Brown A; Aboheimed N; Yip V; Jolly C; Luchian A; Ressel L; Sharma A; Bergfeld W; Ahmed S; Dickinson A; Pirmohamed M; Carr DF
J Dermatol; 2023 Sep; 50(9):1129-1139. PubMed ID: 37269158
[TBL] [Abstract][Full Text] [Related]
10. IL-15/IL-15Rα in SJS/TEN: Relevant Expression of
Bellón T; González-Valle O; Sendagorta E; Lerma V; Martínez Del Río J; Martínez C; Servera G; González-Herrada C; Cachafeiro L; Lorente JA; Cabañas R; Herranz P; de Abajo F;
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009415
[TBL] [Abstract][Full Text] [Related]
11. Diverse expression of TNF-α and CCL27 in serum and blister of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang F; Ye Y; Luo ZY; Gao Q; Luo DQ; Zhang X
Clin Transl Allergy; 2018; 8():12. PubMed ID: 29713456
[TBL] [Abstract][Full Text] [Related]
12. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
[TBL] [Abstract][Full Text] [Related]
13. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.
Marzano AV; Frezzolini A; Caproni M; Parodi A; Fanoni D; Quaglino P; Girgenti V; La Placa M; Fabbri P; Caputo R; Berti E
Int J Immunopathol Pharmacol; 2007; 20(3):557-66. PubMed ID: 17880768
[TBL] [Abstract][Full Text] [Related]
16. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
Chung WH; Hung SI
Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
[TBL] [Abstract][Full Text] [Related]
17. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
Iwai S; Sueki H; Watanabe H; Sasaki Y; Suzuki T; Iijima M
J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564
[TBL] [Abstract][Full Text] [Related]
19. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
[TBL] [Abstract][Full Text] [Related]
20. Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A; Olabi B; Langley A; Beecker J; Mutter E; Shelley A; Worley B; Ramsay T; Saavedra A; Parker R; Stewart F; Pardo Pardo J
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013130. PubMed ID: 35274741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]